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DC-­‐SIGN	  (dendritic	  cell-­‐specific	  ICAM-­‐3	  grabbing	  non-­‐integrin)	  is	  a	  C-­‐type	  lectin	  receptor	  (CLRs)	  present,	  mainly	  in	  dendritic	  
cells	   (DCs),	  as	  one	  of	   the	  major	  pattern	   recognition	   receptors	   (PRRs).	  This	   receptor	  has	  a	   relevant	   role	   in	  viral	   infection	  
processes.	   Recent	   approaches	   aiming	   to	   block	  DC-­‐SIGN	   have	   been	   presented	   as	   attractive	   anti-­‐HIV	   strategies.	   DC-­‐SIGN	  
binds	  mannose	  or	  fucose-­‐containing	  carbohydrates	  from	  viral	  proteins	  such	  as	  the	  HIV	  envelope	  glycoprotein	  gp120.	  We	  
have	   previously	   demonstrated	   that	  multivalent	   dendrons	   bearing	  multiple	   copies	   of	   glycomimetic	   ligands	  were	   able	   to	  
inhibit	  DC-­‐SIGN-­‐dependent	  HIV	  infection	  in	  cervical	  explant	  models.	  Optimization	  of	  glycomimetic	  ligands	  requires	  detailed	  
characterization	  and	  analysis	  of	  their	  binding	  modes	  because	  they	  notably	  influence	  binding	  affinities.	  In	  a	  previous	  study	  
we	  characterized	  the	  binding	  mode	  of	  DC-­‐SIGN	  with	  ligand	  1,	  which	  shows	  a	  single	  binding	  mode	  as	  demonstrated	  by	  NMR	  
and	  X-­‐ray	  crystallography.	  In	  this	  work	  we	  report	  the	  binding	  studies	  of	  DC-­‐SIGN	  with	  pseudotrisaccharide	  2,	  which	  has	  a	  
larger	   affinity.	   Their	   binding	   was	   analysed	   by	   TR-­‐NOESY	   and	   STD	   NMR	   experiments,	   combined	   with	   the	   CORCEMA-­‐ST	  
protocol	  and	  molecular	  modelling.	  These	  studies	  demonstrate	  that	  in	  solution	  the	  complex	  cannot	  be	  explained	  by	  a	  single	  
binding	  mode.	  We	   describe	   the	   ensemble	   of	   ligand	   bound	  modes	   that	   best	   fit	   the	   experimental	   data	   and	   explain	   the	  
higher	  inhibition	  values	  found	  for	  ligand	  2	  
Introduction	  
 
Protein-­‐carbohydrate	   interactions	   are	   key	   in	  many	   important	  
biological	   processes,	   both	   physiological	   and	   pathological.	   In	  
particular,	   these	   interactions	   play	   crucial	   roles	   in	   different	  
aspects	  of	   the	  activation	  of	   the	   immune	   response,	   since	   they	  
are	   involved	   in	   pathogen	   recognition	   and	   in	   the	   interactions	  
with	   the	   cellular	  host	   that	   lead	   to	  pathogen	  neutralization	  or	  
immune	   modulation.	   The	   key	   components	   of	   these	  
interactions	   are	   the	   animal	   lectins.1-­‐3	   A	   large	   part	   of	   animal	  
lectins	   are	   members	   of	   the	   C-­‐type	   or	   Ca2+-­‐dependent	   lectin	  
family.4	   Dendritic	   cells	   (DCs)	   are	   antigen-­‐presenting	   cells	  
(APCs),	   operating	   at	   the	   interface	   of	   innate	   and	   acquired	  
immunity	  as	  they	  recognize	  invading	  pathogens	  and	  thereupon	  
activate	  the	  adaptive	   immune	  response.4	  DCs	  express	  a	  range	  
of	   Pathogen-­‐Recognition	   Receptors	   (PRRs)	   including	   Toll-­‐like	  
receptors	  (TLRs),	  NOD-­‐like	  receptors	  (NLRs),	  and	  C-­‐type	  lectins	  
receptors	   (CLRs).	   DC-­‐SIGN	   (dendritic	   cell	   specific	   ICAM-­‐3	  
(intercellular	  adhesion	  molecule-­‐3)	  grabbing	  non-­‐integrin)	   is	   a	  
PRR	  presents	  on	  the	  surface	  of	  the	  DCs	  that	  belong	  to	  the	  type	  
II	  C-­‐type	  lectin	  family.5	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DC-­‐SIGN	  modulates	   the	   outcome	  of	   the	   immune	   response	   of	  
DCs	   by	   recognition	   of	   a	   broad	   range	   of	   microorganisms,	  
including	  viruses,	  bacteria,	  fungi	  and	  parasites.6-­‐13	  Therefore,	  it	  
is	   considered	   a	   target	   for	   the	   development	   of	   new	  
immunomodulatory	   and	   anti-­‐infective	   therapies.	   Besides,	  
many	  studies	  have	  revealed	  DC-­‐SIGN	  as	  a	  promoter	  of	  both,	  cis	  
and	   trans	   infection,	   enabling	   the	   escape	   from	   host	   immune	  
responses,	  such	  as	  the	  case	  of	  HIV,	  Ebola	  or	  Hepatitis	  C	  virus.	  
14-­‐17	   This	   highlights	   the	   remarkable	   therapeutic	   interest	   in	  
developing	   DC-­‐SIGN	   antagonists	   able	   to	   inhibit	   DC-­‐SIGN-­‐
pathogen	   interactions.	   To	   improve	   the	   affinity	   and	  
pharmacokinetic	   properties	   of	   natural	   ligands	   of	   DC-­‐SIGN,	  
glycomimetics	   based	   on	   different	   lead	   structures	   have	   been	  
proposed.18-­‐25	  
Carbohydrate-­‐binding	   activity	   of	   lectins	   can	   be	   ascribed	   to	   a	  
limited	   portion	   of	   the	   protein	   that	   is	   designated	   as	   the	  
carbohydrate-­‐recognition	   domain	   (CRD).	   The	   CRD	  of	  DC-­‐SIGN	  
has	   a	   globular	   structure	   consisting	   of	   five	   β-­‐strands,	   two	   α-­‐
helices	  and	  four	  disulphide	  bridges.	  A	  loop	  protrudes	  from	  the	  
protein	  surface	  and	   forms	  part	  of	   two	  Ca2+-­‐binding	  sites.	  One	  
of	  these,	  known	  as	  the	  principal	  site,	  is	  essential	  for	  the	  direct	  
coordination	  of	  the	  carbohydrate	  hydroxyl	  groups.	  Four	  amino	  
acids	  (Glu347	  Asn349,	  Glu354	  and	  Asn365)	  interacting	  with	  the	  
Ca2+	   ion	   form	  the	  core	  of	   the	   ligand	  binding	  site	  and	   rule	   the	  
specificity	  of	  the	  structures	  recognized.26-­‐29	  The	  CRD,	  together	  
with	   the	   neck	   region	   that	   promotes	   the	   lectin’s	  
homotetramerization,	   constitute	   the	   extracellular	   domain	  
(ECD)	  of	  DC-­‐SIGN.	  
DC-­‐SIGN	   binds	   mannose	   or	   fucose	   epitopes	   present	   in	   the	  
pathogen’s	   envelope	   glycoproteins	   such	   as	   gp120	  
(Man9GlcNAc2)	   or	   blood	   group	   B	   antigens	   (Lewis-­‐type).	   Both	  
structures	  bind	  DC-­‐SIGN	  CRD	  via	  Ca2+-­‐mediated	   interaction	   in	  
the	  same	  binding	  pocket,	  named	  the	  primary	  binding	  site,	  and	  
with	  the	  same	  Ca2+	  atom.26-­‐29	  
We	   have	   investigated	   in	   detail	   the	   interactions	   of	   simple	  
oligosaccharides	   and	   new	   glycomimetic	   ligands	   bearing	  
mannose	   or	   fucose	   structures	   with	   DC-­‐SIGN	   by	   NMR	  
spectroscopy	   combined	   with	   computational	   methods	   to	  
address	   the	  development	   of	   further	   generations	   of	   improved	  
glycomimetic	   ligands.18,	   21,	   23,	   24,	   30-­‐36	  These	  studies	  have	   led	  us	  
to	  propose	   that,	   in	   solution,	  mannose-­‐	   and	   fucose-­‐containing	  
LewisX	   mimics	   interact	   within	   the	   same	   binding	   site	   with	  
different	   but	   simultaneous	   modes	   in	   a	   multimodal	   fashion,	  
according	  to	  NMR	  combined	  with	  molecular	  modeling	  and	  full	  
matrix	   relaxation	   calculations.30,	   33,	   35-­‐38	   In	   a	   recent	   work	   by	  
others	   this	  multimodal	   binding	   is	   described	   in	   another	   lectin	  
(HML2	  interacting	  with	  galactosides)	  demonstrating	  that	  is	  not	  
an	   exceptional	   feature.39	   A	   recent	   analysis	   using	   high-­‐
resolution	  multinuclear	  NMR	   spectroscopy	  by	  Prestegard	  and	  
coworkers	   provided	   the	   3D	   structure	   of	   the	   complex	   of	   DC-­‐
SIGN	   with	   LewisX,40	   in	   agreement	   with	   our	   studies	   on	   the	  
fucose-­‐containing	  ligands.	  21	  
Based	  on	  a	  similar	  concept,	  to	  mimic	  the	  natural	  Manα1-­‐2Man	  
and	  Manα1-­‐2Manα1-­‐6Man,	  a	  pseudo-­‐mannobioside	  (1)	  and	  a	  
pseudo-­‐mannotrioside	  (2),	  were	  synthesized	  and	  tested.20,	  24,	  41	  
Recently	   we	   have	   fully	   characterized	   the	   binding	   mode	   of	   1	  
within	  the	  DC-­‐SIGN	  CRD	  by	  a	  combination	  of	  NMR	  analysis,	  X-­‐
ray	  crystallography,	  computational	  tools	  and	  other	  biophysical	  
methods.24	   We	   have	   demonstrated	   that	   it	   corresponds	   to	   a	  
unique	  well-­‐defined	  orientation,	  different	  from	  any	  of	  the	  two	  
simultaneous	  binding	  modes	  described	  for	  the	  natural	  Manα1-­‐
2Man.31	  
The	   linear	   pseudo-­‐mannotrioside	   2	   showed	   an	   inhibitory	  
potency	  one	  order	  of	  magnitude	  higher	  than	  1	  (IC50	  measured	  
by	   SPR	   competition	   experiments).24	   However,	   no	   explanation	  
for	   the	  higher	  affinity	  and	  activity	   could	  be	   inferred	   from	  the	  
solid-­‐state	   structure	   as	  no	   additional	   contacts	  were	  observed	  
in	   comparison	   to	   the	   pseudo-­‐mannobioside	  1.[6h]	   This	   affinity	  
difference	   between	  1	   and	  2	   is	   lost	  when	   the	   compounds	   are	  
tethered	   to	   multivalent	   scaffolds	   and	   both	   have	   similar	  
improved	  affinity.20	  On	   the	  other	  hand,	  data	   from	  alternative	  
biophysical	   techniques	   such	   as	   Isothermal	   Titration	  
Calorimetry	   (ITC),	  Analytical	  Ultra	  Centrifugation	   (AUC),	   Static	  
Ligth	   Scattering	   (SLS),	   and	   Dynamic	   Light	   Scattering	   (DLS),	  
indicate	  the	  formation	  of	  a	  ternary	  complex,	  where	  2	  acts	  as	  a	  
bridge	   capable	  of	   clustering	   two	  DC-­‐SIGN	  ECD	  units	   (DC-­‐SIGN	  
tetramers)	   for	   low	   ligand-­‐to-­‐protein	   ratios	   (2/DC-­‐SIGN	   ECD	  
ratios	  between	  0.5	  and	  5).25	  
Since	   for	   large	   ligand-­‐to-­‐protein	   ratios	   the	   binary	   ligand-­‐
protein	   complex	   is	   favoured,	   we	   decided	   to	   carry	   out	   STD	  
NMR42	  and	  transfer	  NOESY43	  studies	  on	  the	  binding	  process	  of	  
2	   with	   DC-­‐SIGN	   ECD	   in	   the	   presence	   of	   a	   large	   excess	   of	   2	  
(2/DC-­‐SIGN	   ECD	   ratio	   52:1).	   Our	   aim	   was	   two-­‐fold:	   i)	   to	  
compare	   that	   structural	   information	  with	   that	   obtained	   from	  
X-­‐ray	   crystallography	   in	   which	   a	   single	   binary	   protein-­‐ligand	  
complex	   was	   observed,	   and	   ii)	   to	   characterize	   the	   binding	  
under	   more	   relevant	   conditions	   to	   explain	   the	   absence	   of	  
multivalency	  effect.25	  	  
Therefore,	   herein	   we	   provide	   an	   analysis	   of	   the	   molecular	  
recognition	  of	  mimic	  2	  by	  DC-­‐SIGN,	  using	  large	  excess	  of	  ligand	  
(52:1)	   in	  order	  to	  describe	  at	  atomic	   level	  the	  binary	  complex	  
2/DC-­‐SIGN	   (ECD)	   by	   a	   combination	   of	   NMR	   experiments	   in	  
solution	   and	   computational	   techniques	   (molecular	   modelling	  
and	  CORCEMA-­‐ST44).	  
Results	  and	  Discussion	  
The	  structure	  of	   free	  pseudo-­‐mannotrioside	  2	  was	  studied	  by	  
NMR	  and	  it	  was	  fully	  consistent	  with	  the	  smaller	  homologous	  1	  
(see	   details	   in	   the	   experimental	   part).25	  We	   have	   performed	  
the	   NMR	   studies	   of	   the	   interaction	   of	   the	   pseudo-­‐
mannotrioside	   with	   DC-­‐SIGN	   ECD,	   using	   the	   ligand	   with	   an	  
attached	   triazole	   moiety	   at	   the	   mannose	   reducing	   ring	   (M’,	  
Scheme	   1).	   The	   triazole	   moiety	   improves	   the	   spectral	  
dispersion,	   while	   is	   not	   affecting	   the	   binding	   nor	   the	   three-­‐
dimensional	   structure.24	   The	   3D	   structure	   of	   the	   Man-­‐
cyclohexyl	  moiety	  of	  2	   is	   consistent	  with	   the	   structure	  of	   the	  
common	  part	  of	  1,	  while	  the	  1-­‐6	  linkage	  of	  the	  mannose	  at	  the	  
reducing	   end	   has	   the	   expected	   structural	   features	   of	   a	   1-­‐6	  
linkage	  of	  a	  gluco	  configuration,	  in	  equilibrium	  between	  gg	  and	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Figure	  1.	  STD	  NMR	  study	  of	  the	  interaction	  of	  ligand	  2	  with	  DC-­‐SIGN	  ECD	  in	  solution.	  (a)	  
1H	  NMR	  reference	  spectrum	  (off-­‐resonance	   frequency	  40	  ppm)	  and	  (b)	  STD	  spectrum	  
(on-­‐resonance	  frequency	  0	  ppm)	  of	  a	  sample	  containing	  1	  mM	  of	  2	  and	  19	  μM	  of	  DC-­‐
SIGN	  ECD,	  at	  25°C	  (500	  MHz).	  Key	  proton	  signals	  are	  labeled	  in	  (a).	  
introduction	   of	   the	   triazole	   moiety	   in	   this	   case	   is	   less	  
pronounced	   than	   for	   the	   analogous	   1	   and	   some	   overlap	   is	  
observed	   (Figure	   1a).	   The	   chemical	   shifts	   of	   the	  mannose	   at	  
the	   reducing	   end	   (M’)	   shift	   from	   the	   normal	   values	   towards	  
high	   field	   suggesting	   some	   shielding	   effect	   of	   the	   aromatic	  
electronic	   cloud	   of	   the	   triazole	   moiety.	   The	   NOE	   values	   are	  
consistent	   with	   an	   extended	   conformation	   with	   similar	  
structure	   for	   the	   Man	   –	   cyclohexyl	   pseudodisaccharide	   than	  
1.45	  The	  rest	  of	  the	  molecule	  exhibits	   larger	  flexibility	   likely	  to	  
be	  due	  to	   the	  1-­‐6	   linkage,	  which	  has	  one	  additional	   rotatable	  
bond.	  	  
In	   a	   previous	   work	   by	   us,	   mimic	   2	   was	   co-­‐crystallized	   with	  
monomeric	   DC-­‐SIGN	   CRD	   and	   the	   X-­‐ray	   structure	  was	   solved	  
(PDB	  2xr6),25	  providing	  a	  valuable	  structural	   insight	  aiding	  our	  
parallel	   analysis.	   X-­‐ray	   reported	   a	   single	   binding	   mode	   of	   2,	  
with	  identical	  orientation	  of	  the	  common	  part	  of	  the	  molecule	  
as	   for	   1,	   while	   the	   reducing	   mannose	   in	   the	   pseudo-­‐
mannotrioside	   appeared	   solvent	   exposed	   without	   new	  
additional	   contacts	   observed	   compared	   with	   the	   pseudo-­‐
mannobioside	   1.25	   Thus,	   no	   explanation	   for	   the	   higher	  
inhibition	   values	   for	   the	   pseudo-­‐mannotrioside	   could	   be	  
deduced	   from	   the	   solid-­‐state	   structure.	   Data	   from	   other	  
techniques	  under	  low	  ligand-­‐to-­‐protein	  ratios	  indicated	  that	  2	  
could	   bridge	   two	   DC-­‐SIGN	   ECD	   units.25	   Therefore,	   we	   have	  
performed	   STD	   NMR42	   and	   transfer	   NOESY46	   studies	   of	   the	  
binding	   process	   of	   2	   with	   DC-­‐SIGN	   ECD	   under	   conditions	   of	  
large	   excess	   of	   ligand	   (52:1)	   to	   favour	   the	   1:1	   complex.	   The	  
STD	   NMR	   experiments	   of	   2	   in	   the	   presence	   of	   DC-­‐SIGN	   ECD	  
clearly	  indicate	  binding	  in	  solution	  (Figure	  1	  and	  5).	  In	  spite	  of	  
a	  significant	  signal	  overlap,	  some	  key	  intense	  STD	  signals	  could	  
be	   accurately	   integrated,	   and	   their	   growth	   with	   saturation	  
time	   is	   shown	   in	   figure	   2a.	   Their	   intensities	   reflect	   short	  
distances	  to	  the	  protein	  surface	   in	   the	  bound	  state,	  and	  their	  
distribution	   in	   relative	   terms	   shows	   the	   main	   parts	   of	   the	  
ligand	  contacting	  the	  protein,	  called	  STD	  NMR	  binding	  epitope	  
(Figure	  2a	  and	  2c).	  47	  
	  
Figure	  2.	  STD	  NMR	  curves	  and	  ligand	  epitope	  map	  of	  2.	  (a)	  Experimental	  STD	  build-­‐up	  
curves	  of	   the	  binding	  of	  2	   to	  DC-­‐SIGN	  as	  a	   function	  of	  saturation	  time	  (b)	  Theoretical	  
STD	  intensities	  predicted	  by	  CORCEMA-­‐ST	  using	  the	  Cartesian	  coordinates	  of	  the	  X-­‐ray	  
structure.	  (c)	  Ligand	  epitope	  map	  of	  2	  binding	  to	  DC-­‐SIGN	  at	  25°C	  showing	  STD	  relative	  
values	  at	  the	  shortest	  saturation	  time	  0.5	  s,	  for	  non	  overlapped	  protons.	  (See	  ESI)	  
The	  binding	  epitope	  indicates	  that	  the	  non-­‐reducing	  mannose	  
ring	   (M)	  makes	  additional	  contacts	  with	  the	  protein,	  and	  that	  
the	   strongest	   saturation	   transfer	  occurs	  on	  proton	  H6ax-­‐C	  on	  
the	   cyclohexyl	   ring	   of	   the	   ligand	   (Figure	   2).	   This	   analysis	   also	  
confirmed	  that	  the	  triazole	  moiety	  is	  not	  involved	  in	  significant	  
protein	  contacts.	  	  
The	   STD	   results	   for	   the	   two	   first	   residues	   (non-­‐reducing	  
mannose,	  M,	  and	  cyclohexyl,	  C)	  are	  similar	   to	   those	  obtained	  
for	   the	   pseudo-­‐mannobioside	   1	   constituted	   by	   the	   same	  
residues.[6g]	   They	   are	   compatible	   with	   a	   major	   bound	  
conformation	   of	   pseudo-­‐mannotrioside	   2	   in	   a	   binding	   mode	  
equivalent	  to	  that	  of	  1.	  
This	   is	   also	   in	   agreement	   with	   crystal	   data,	   as	   a	  
superimposition	   of	   both	   X-­‐ray	   complexes25	   shows	   identical	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Figure	   3.	   3D	   models	   of	   the	   interaction	   of	   2	   with	   DC-­‐SIGN	   obtained	   by	   rigid-­‐body	  
rotations	   and	   translations	   of	   the	   ligand	   at	   the	   binding	   site,	   starting	   from	   the	  
crystallographic	  position,	  based	  on	  a	  Ca2+	  coordination	  search	  The	  corresponding	  STD	  
intensities	   predicted	   for	   each	   model	   by	   CORCEMA-­‐ST	   are	   shown.	   The	   theoretical	  
structures	   were	   named	   according	   to	   an	   abbreviated	   nomenclature	   as	   "rotated”,	  
"inverted",	  and	  "inverted-­‐rotated".	  Rotated	  model	  (E=	  -­‐1920.6	  kJ/mol)	  was	  obtained	  by	  
a	  180º	   rotation	  around	  an	  axis	  perpendicular	   to	   the	  C3-­‐C4	  bond	  of	   the	  non-­‐reducing	  
mannose,	  resulting	  an	   interaction	  “O4-­‐O3	  type”	  with	  the	  Ca2+	  atom,	  rather	  than	  “O3-­‐
O4”	   (nomenclature	   by	   setting	   Val351	   residue	   on	   the	   right	   of	   the	   observer,	   as	   a	  
reference).	   In	  the	  “inverted”	  model	   (E=	  -­‐1871.2	  kJ/mol)	   the	  reducing	  mannose	  (M')	   is	  
interacting	   in	  the	  same	  position	  as	  the	  non-­‐reducing	  sugar	  ring	  (M)	   in	  the	  crystallized	  
pose	  (O3-­‐O4)	  and	  in	  the	  "inverted-­‐rotated"	  (E=	  -­‐1894.8	  kJ/mol)	  the	  coordination	  of	  the	  
reducing	  mannose	  to	  Ca2+	  is	  rotated	  by	  180º	  (O4-­‐O3	  type).	  Only	  those	  protons	  signals	  
that	  could	  be	  accurately	  integrated	  were	  plotted.	  
moiety,	   in	   which	   the	   H6ax-­‐C	   proton	   is	   situated	   close	   to	   the	  
methyl	   groups	   of	   Val351,	   explaining	   the	   large	   saturation	  
received	  (100%).	  In	  addition	  to	  these	  favourable	  van	  der	  Waals	  
interactions,	  the	  non-­‐reducing	  mannose	  residue	  coordinates	  
the	  Ca2+	  ion	  through	  its	  trans-­‐diequatorial	  hydroxyl	  groups	  M-­‐
OH3	  and	  M-­‐OH4.24,	  25	  
However,	   and	   in	   contrast	   to	   the	   STD	   NMR	   results	   for	   1	   that	  
were	   in	   complete	   agreement	   with	   the	   X-­‐ray	   structure	   (PDB	  
code	  2it6),	  the	  observed	  distribution	  of	  saturation	  transferred	  
to	   the	  protons	  of	   compound	  2	  did	  not	  accurately	   fit	  with	   the	  
structure	  of	  the	  crystallographic	  complex	  (PDB	  code	  2xr6).25	  	  
While	  in	  the	  X-­‐ray	  structure	  the	  reducing	  mannose	  ring	  (M')	  is	  
solvent	   exposed,	   in	   solution	   we	   clearly	   detect	   transfer	   of	  
saturation	  to	  H4-­‐M’	  and	  H5-­‐M’	  (Figure	  2).	  This	  is	  incompatible	  
with	   the	   geometry	   of	   the	   diffraction	   complex.	   Moreover,	  
theoretical	   STD	   calculations	   performed	   with	   the	   program	  
CORCEMA-­‐ST44	  using	  the	  X-­‐ray	  coordinates	  of	  the	  complex	  did	  
not	   reproduce	   the	   NMR	   observations.	   CORCEMA-­‐ST	   predicts	  
lower	   intensity	   for	   H6ax	   and	   H6eq	   of	   the	   cyclohexyl	   ring	   (C)	  
and,	   as	   expected,	   close	   to	   zero	   STD	   values	   for	   the	   reducing	  
mannose	  residue	  H4-­‐M’	  and	  H5-­‐M’	  (Figure	  2b).	  
Compounds	   1	   and	   2,	   in	   spite	   of	   their	   structural	   similarities	  
have	   different	   outcome	   from	   STD-­‐NMR	  experiments.	  We	   can	  
discard	  a	   second	   low	  affinity	  binding	   site	   in	   the	  protein	   for	  2	  
contributing	   to	   the	   STD	  effects,	   under	   the	   conditions	   for	   STD	  
experiments	   (large	   excess	   of	   ligand).	   This	   circumstance	   was	  
not	   detected	   in	   the	   case	   of	   1,25	   so	   we	   can	   exclude	   the	  
participation	   of	   an	   extra	   binding	   site	   taking	   place	   only	   for	  
ligand	  2	  and	  not	   for	  1,	  as	  2	   corresponds	  to	  the	  structure	  of	  1	  
with	   an	   additional	   mannose.	   Consequently,	   the	   most	   likely	  
explanation	  of	  the	  discrepancy	  between	  1	  and	  2	  STD	  results	  is	  
the	  existence	  of	  an	  additional	  minor	  mode	  of	  interaction	  for	  2	  
in	  the	  same	  binding	  site	  in	  fast	  equilibrium	  with	  the	  major	  one	  
observed	  in	  the	  X-­‐ray	  complex	  (PDB	  code	  2xr6)	  and	  in	  solution	  
between	   DC-­‐SIGN	   with	   1.25	   Based	   on	   earlier	   works	   with	  
mannose-­‐based	   ligands,31	   potential	   additional	   poses	   of	   2	  
contributing	  to	  the	  STD	  signals	  via	  the	  reducing	  end	  mannose	  
interacting	  into	  the	  same	  binding	  site	  could	  be	  at	  the	  origin	  of	  
this	   observation.	   This	   situation	   where	   the	   fast	   equilibrium	  
between	   several	   binding	  modes	   into	   the	   same	  binding	   site	   is	  
revealed	  by	  distortions	  of	  the	  binding	  epitope,	  as	  this	  case,	  has	  
been	  already	  described	  for	  this	  particular	  protein.21,	  23,	  31	  
Our	   first	   attempt	   to	  explain	   the	  NMR	  data	   in	   solution	  was	   to	  
consider	  that	  the	  larger	  flexibility	  of	  the	  1-­‐6	  linkage	  might	  be	  at	  
the	  origin	  of	   the	  discrepancy,	   as	   several	   conformations	   could	  
interact	  with	  DC-­‐SIGN	  CRD.	  We	  built	  additional	  models	  based	  
on	  a	   1→6	   torsional	   search.	   Starting	   from	   the	  X-­‐ray	   structure,	  
(PDB	  code	  2xr6),	   the	  dihedral	  angles	  Ψ	  and	  ω	  were	  varied	   to	  
generate	   an	   ensemble	   of	   all	   the	   potential	   conformers.	  
Complexes	  with	  DC-­‐SIGN	  were	  constructed	  and	  superimposed	  
onto	  the	  positions	  of	  the	  common	  pseudodisaccharide	  (M	  and	  
C	   residues,	   Scheme	   1).	   They	   were	   further	   energy	   minimized	  
and	   those	   with	   severe	   steric	   clashes	   into	   the	   complex	   were	  
discarded.	  
The	  resulting	   initial	  models	  (A,	  B,	  C,	  and	  D	  see	  ESI	  Figures	  S1-­‐
S4)	   presented	   distances	   in	   agreement	   with	   NOE	   data.	  
Nevertheless,	  the	  H4	  and	  H5	  protons	  of	  the	  reducing	  mannose	  
(M')	  remained	  solvent	  exposed	  and	  we	  did	  not	  appreciate	  any	  
significant	   effect	   on	   their	   STD	   theoretical	   intensities	   upon	  
changes	   in	   1-­‐6	   torsion	   angles.	   In	   general,	   the	   theoretical	   STD	  
build-­‐up	  curves	  obtained	  from	  CORCEMA-­‐ST	  calculations	  using	  
the	   coordinates	   of	   these	   molecular	   models	   were	   practically	  
equivalent	   to	   each	   other	   and	   very	   similar	   to	   those	   of	   the	  
crystallographic	   complex	   (see	   ESI).	   Thus,	   all	   the	   attempts	   to	  
explain	   the	   STD	   NMR	   results	   based	   on	   variations	   of	   the	   1-­‐6	  
linkage	  were	  unsuccessful.	  	  
Then,	  we	  considered	  additional	  potential	  models	  of	  interaction	  
based	  on	  the	  Ca2+	  coordination	  of	  two	  hydroxyl	  groups	  of	  the	  
ligand	  within	   the	  DC-­‐SIGN	  binding	   site	   (Figure	  3).	  We	  applied	  
rigid-­‐body	  rotations	  and	  translations	  to	  the	  ligand	  starting	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Table	   1	   NOE	   R-­‐Factor	   as	   function	   of	   the	   proportional	   weight	   of	   the	   initial	   Ca2+	  
coordination	  calculated	  structure	  vs	  the	  inverted-­‐rotated	  mode	  
	  
Initial-­‐calculated	   Inverted-­‐Rotated	   R-­‐Factor	  
100	   0	   0.46	  
80	   20	   0.22	  
60	   40	   0.26	  
40	   60	   0.51	  
20	   80	   0.79	  
0	   100	   1.08	  
	   	   	  
from	   the	   crystallographic	   position,	   conserving	   the	   OH-­‐3	   and	  
OH-­‐4	  Ca2+	  coordination.	  
Three	   operations	   were	   considered:	   swapping	   between	   OH-­‐3	  
and	   OH-­‐4	   positions	   (rotations),	   changing	   the	   coordinating	  
mannose	   residue	   (inversion),	   and	   the	   combination	   of	   both	  
(inversion-­‐rotation).21,	   31	  The	  obtained	  structures	  were	  named	  
according	  to	  an	  abbreviated	  nomenclature	  relative	  to	  the	  X-­‐ray	  
complex	   (Figure	  3	   and	  Experimental	   Section).	   The	  CORCEMA-­‐
ST	   STD	   values	   for	   each	   individual	   mode	   of	   interaction	   were	  
incompatible	  with	  the	  experimental	  STD	  NMR	  results,	  meaning	  
that	  a	   single	  3D	  molecular	  binding	   form	  was	  not	  able	   to	   fully	  
explain	  the	  NMR	  data	  in	  solution.	  
Thus,	   we	   decided	   to	   carry	   out	   an	   analysis	   of	   the	   STD	   NMR	  
observations	   assuming	   that	   two	   different	   binding	   modes,	  
within	  the	  same	  site,	  contribute	  to	  the	  final	  intensities.	  In	  this	  
way,	   the	   total	   saturation	   observed	   in	   the	   STD	   experiment	  
would	   be	   the	   weighted	   average	   of	   the	   accumulated	  
saturations	   corresponding	   to	   each	   binding	   mode.	   In	   this	  
quantitative	   analysis,	   we	   only	   considered	   those	   signals	   that	  
could	   be	   accurately	   integrated.33	   We	   used	   the	   initial	   slope	  
approach	   (STD0)	   to	   study	   this	   bimodal	   system	   in	   order	   to	  
ensure	  that	  the	  individual	  STD	  values	  are	  not	  affected	  by	  cross-­‐
rebinding	  processes	  during	  the	  saturation	  time	  that	  would	  mix	  
the	  STD	  information	  in	  a	  very	  complex	  way.37	  
	  
Following	  the	  initial	  slope	  approach,	  the	  STD0	  of	  the	  ensemble	  
can	   be	   estimated	   by	   the	   addition	   of	   the	   STD0	   contributions	  
from	  the	  individual	  components.	  
For	  this	  multimodal	  binding	  analysis	  of	  the	  STD	  data	  only	  those	  
protons	   that	   could	   be	   accurately	   integrated	  were	   considered	  
avoiding	   uncertain	   contributions	   in	   the	   case	   of	   overlapped	  
signals.	  Unfortunately,	  signal	  H6eq-­‐C,	  which	  has	  the	  strongest	  
STD	   effect,	   did	   not	   have	   enough	   dispersion	   to	   be	   quantified.	  
The	  theoretical	  bimodal	  binding	  equilibrium	  was	  considered	  in	  
all	  cases	  as	  pair-­‐wise	  combinations	  of	  the	  initial	  structure,	  with	  
the	  coordination	  to	  Ca2+	  similar	  to	  the	  X-­‐ray	  structure,	  with	  any	  
of	  the	  other	  three	  molecular	  models	  of	  the	  complexes	  (Figure	  
4	  and	  Table	  1).	   The	  NOE	  R-­‐factor	   indicated	   the	  quality	  of	   the	  
prediction.	   We	   found	   that	   a	   reasonable	   theoretical	   –	  
experimental	   agreement	   (NOE	   R-­‐factor	   =	   0.2)48,	   49	   could	   be	  
reached	   by	   considering	   the	   equilibrium	   of	   the	   following	   two	  
bound	  conformations	  in	  solution:	  the	  major	  one	  (~	  80%)	  from	  
the	  initial	  structure	  and	  a	  minor	  contribution	  (~	  20%)	  from	  the	  
complex	  as	  arranged	  in	  the	  "inverted-­‐rotated"	  model	  (Table	  1).	  
Figure 4. Combination of the binding modes of pseudo-mannotrioside with DC-
SIGN receptor that have shown the best fit with the experimental STD NMR 
intensities and considering a bimodal system (top). The lowest NOE R-factor, as 
well as the simple comparison of the experimental and predicted STD growth 
curves, proves that a major contribution (~ 80%) of the X-ray complex 
represented by a superimposition of the ω rotamers A, B, C, and D (bottom left) 
combined with a minor one from the "inverted-rotated" model (~ 20%) (bottom 
right), would explain the experimental STD NMR outcomes in solution. 
	  
However,	   the	   major	   binding	   mode	   is	   still	   compatible	   with	   a	  
mixture	   of	   different	   conformers	   (Figure	   4	   bottom	   left,	   ESI	  
figures	  S1-­‐S4).	  The	  absence	  of	  key	  NOE	  cross	  peaks	   (Figure	  5)	  
did	   not	   allow	   determining	   the	   conformation	   around	   the	  
cyclohexyl	   1→6	   mannose	   linkage,	   very	   likely	   due	   to	   an	  
increased	   flexibility	   at	   that	   region	   of	   the	   molecule.50	   We	  
carried	  out	  NOESY	  experiments46,	   51	  on	  pseudo-­‐mannotrioside	  
2	   both	   free	   and	   in	   the	   presence	   of	   DC-­‐SIGN.	   Analysis	   of	   the	  
spectra	   (Figure	   5)	   led	   us	   to	   the	   conclusion	   that	   there	   are	   no	  
important	  conformational	  changes	   in	   the	   ligand	  upon	  binding	  
to	  DC-­‐SIGN.	  Only	  irrelevant	  differences	  in	  the	  NOE	  pattern	  are	  
attributable	  to	  protein	  mediated	  spin	  diffusion.52,53	  
The	   conformation-­‐defining	   key	   NOEs	   that	   could	   be	  
unambiguously	   detected	   (highlighted	  by	   a	   square	   in	   figure	   5)	  
are	   either	   present	   (H1-­‐M/H3eq-­‐C)	   or	   absent	   (H5-­‐M'/H6eq-­‐C)	  
equally	   in	   both	   spectra,	   indicating	   the	   same	   conformation	   in	  
the	   free	   and	   bound	   states.	   As	   in	   the	   STD	   NMR	   study,	   the	  
transfer	   NOESY	   data	   did	   not	   fully	   agree	   with	   the	   X-­‐ray	  
complex.	  In	  the	  crystal	  structure,	  the	  conformation	  around	  the	  
1,6	   linkage	   between	   the	   cyclohexyl	   (C)	   and	   the	   reducing	  
mannose	  ring	  (M’)	  should	  lead	  to	  a	  strong	  H5-­‐M’/H6eq-­‐C	  NOE,	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Figure	  5.	  Comparison	  of	  NOESY	  spectra	  (298	  K,	  500	  MHz)	  of	   ligand	  2,	   (top)	   free	  
(2.3	  mM,	  mixing	  time	  500	  ms),	  and	  (bottom)	  bound	  to	  DC-­‐SIGN	  (1	  mM,	  19	  μM	  
protein,	  mixing	  time	  300	  ms).	  The	  conformation-­‐defining	  key	  NOEs	  (highlighted	  
by	  a	  square)	  are	  either	  present	  (H1-­‐M/H3eq-­‐C)	  or	  absent	  (H5-­‐M'-­‐H6eq-­‐C)	  equally	  
in	  both	  spectra,	  indicating	  the	  same	  conformation	  in	  the	  free	  and	  bound	  states.	  
Cross	  peaks	  not	  observed	  in	  the	  bound	  state,	  indicative	  of	  high	  flexibility	  of	  the	  
reducing	  end	  in	  the	  protein-­‐ligand	  complex,	  are	  surrounded	  by	  a	  circle.	  
which	   was	   not	   observable	   in	   any	   of	   the	   spectra	   (Figure	   5).	  
However,	   we	   observed	   a	   strong	   H1-­‐M/H3eq-­‐C	   NOE,	  
characteristic	   to	   the	   extended	   conformation	   around	   the	   1,2	  
linkage	   of	   the	   mannose-­‐cyclohexyl	   moiety	   of	   the	   pseudo-­‐
trisaccharide,	   compatible	   with	   the	   X-­‐ray	   structure,45	   and	  
similar	  to	  the	  previously	  studied	  pseudo-­‐mannobioside	  1.24	  	  
Results	  and	  Discussion	  
	  
Synthetic	  procedures.	  
Thin	   layer	  chromatography	  (TLC)	  analyses	  were	  performed	  on	  
silica	   gel	   60	   F254	   precoated	   on	   aluminium	   plates	   (Merck)	   and	  
the	   compounds	   were	   detected	   by	   staining	   with	   sulfuric	  
acid/ethanol	   (1:9),	   with	   cerium	   (IV)	   sulfate	   (10	  
g)/phosphomolybdic	  acid	   (13	  g)/sulfuric	  acid	   (60	  mL)	   solution	  
in	  water	  (1	  L),	  or	  with	  anisaldehyde	  solution	  [anisaldehyde	  (25	  
mL)	  with	  sulfuric	  acid	  (25	  mL),	  ethanol	  (450	  mL)	  and	  acetic	  acid	  
(1	   mL)],	   followed	   by	   heating	   at	   over	   200ºC.	   Column	  
chromatography	  was	  carried	  out	  on	  silica	  gel	  60	  (0.2-­‐0.5	  mm,	  
0.2-­‐0.063	  mm	   or	   0.040-­‐0.015	  mm;	  Merck).	   1H-­‐	   and	   13C-­‐NMR	  
spectra	  were	  acquired	  on	  Bruker	  DPX-­‐300,	  Avance	  III-­‐400	  and	  
DRX-­‐500	   spectrometers.	   Unit	   A	   refers	   to	   the	   reducing	   end	  
monosaccharide	   in	   the	   NMR	   data.	   Electrospray	  mass	   spectra	  
(ESI	  MS)	   were	   carried	   out	   with	   an	   Esquire	   6000	   ESI-­‐Ion	   Trap	  
from	  Bruker	  Daltonics.	  
Synthesis	  of	   compound	  2.	  Pseudo-­‐mannotrioside	  220	   (20	  mg,	  0.03	  
mmol),	  propargyl	  alcohol	  (10	  µL,	  0.02	  mmol),	  CuSO4.5H2O	  (0.8	  mg,	  
0.003	  mmol),	  sodium	  ascorbate	  (1.3	  mg,	  0.006	  mmol)	  and	  TBTA	  (3.4	  
mg,	  0.006	  mmol)	  were	  dissolved	  in	  1	  mL	  of	  THF/H2O	  (1:1).	  After	  1.5	  
h,	  the	  solvent	  was	  evaporated	  and	  the	  resulting	  crude	  was	  purified	  
by	   flash	   chromatography	   in	   silica	   (CH2Cl2/MeOH	   9:1,	   8:2.5,	   7:3),	  
furnishing	  17	  mg	   (81%	  yield)	  of	   compound	  2	  as	  oil.	   1H	  NMR	   (D2O,	  
500	  MHz):	  δ	  8.04	  (s,	  1H,	  Htriazol),	  5.03	  (bs,	  1H,	  H-­‐1mann´),	  4.81	  (bs,	  
1H,	  H-­‐1mann),	  4.73	  (s,	  2H,	  CtriazolCH2OH),	  4.71-­‐4.68	  (m,	  2H,	  CH2N),	  
4.10-­‐4.05	   (m,	   1H,	   OCH2CH2N),	   4.04-­‐3.99	   (m,	   2H,	   H-­‐2mann´,	  
O6mannCHCHO),	   3.98-­‐3.94	   (m,	   1H,	   OCH2CH2N),	   3.92-­‐3.89	   (m,	   2H,	  
H-­‐2mann,	   H-­‐6mann´),	   3.88-­‐3.83	   (m,	   1H,	   H-­‐3mann´),	   3.76-­‐3.70	   (m,	  
9H,	   H-­‐6mann´,	   H-­‐6mann,	   O6mannCHCHO,	   CH3),	   3.69-­‐3.63	   (m,	   4H,	  
H-­‐6mann,	  H-­‐3mann,	  H-­‐4mann´,	  H-­‐5mann´),	  3.58	  (at,	  J	  =	  9.5	  Hz,	  1H,	  
H-­‐4mann),	   3.12-­‐3.07	   (m,	   1H,	   H-­‐5mann),	   2.97-­‐2.93	   (m,	   2H,	  
CHCOOCH3),	   2.20-­‐2.11	   (m,	   2H,	   OCHCHeqHax),	   1.87-­‐1.74	   (m,	   2H,	  
OCHCHeqHax).	   13C	   NMR	   (CDCl3,	   100	   MHz):	   δ	   177.7,	   177.4	   (C=O),	  
146.9	  (Ctriazol),	  124.5	  (CHtriazol),	  99.6	  (C-­‐1mann),	  98.4	  (C-­‐1mann´),	  
74.3	   (C-­‐1CH),	   73.3	   (C-­‐4mann¨),	   71.7	   (C-­‐5mann),	   70.8	   (C-­‐3mann),	  
70.4	   (C-­‐2mann´,	  C-­‐2CH),	  69.7	   (C-­‐2mann),	  69.5	   (C-­‐3mann´),	  66.7	   (C-­‐
5mann´),	   66.5	   (C-­‐4mann),	   65.7	   (OCH2CH2N),	   60.9	   (C-­‐6),	   54.5	  
(CtriazolCH2OH),	  52.5	  (CH3),	  49.9	  (OCH2CH2N),	  38.9	  (C-­‐4CH,	  C-­‐5CH),	  
26.8	  (C-­‐6CH),	  26.5	  (C-­‐3CH)	  ESI-­‐MS	  calc.	  for	  C27H43N3O17	  (m/z):	  681.3;	  
found:	  704.3	  [M+Na].	  
	  
NMR	  spectroscopy	  experiments	  
NMR	   spectroscopy	   experiments	  were	   performed	  on	   a	   Bruker	  
Avance	   DRX	   500	   MHz	   spectrometer	   equipped	   with	   a	   5	   mm	  
inverse	   triple-­‐resonance	   probe	   head,	   at	   298	   K.	   The	   samples	  
were	  prepared	  at	  2.3	  mM	  in	  550	  μL	  of	  99.9%	  D2O	  for	  complete	  
assignment	   of	   the	   ligand	   signals	   and	   at	   1	  mM,	   in	   buffer	   D2O	  
(150	   mM	   NaCl,	   4	   mM	   CaCl2,	   25	   mM	   Tris-­‐d11,	   pD	   8)	   for	   the	  
experiments	  in	  the	  presence	  of	  the	  receptor	  (DC-­‐SIGN	  ECD	  19	  
μM).	   The	   same	   sample	   was	   used	   for	   both,	   STD	   NMR	   and	  
transfer	  NOESY	  experiments.	  NOESY	  experiments	  were	  carried	  
out	  using	  a	  phase	  sensitive	  pulse	  program	  with	  gradient	  pulses	  
in	   the	   mixing	   time	   and	   with	   presaturation54	   Mixing	   times	   of	  
150,	  300,	  and	  500	  ms	  were	  used	  for	  TR-­‐NOESY	  spectra	  and	  500	  
ms	  for	  NOESY	  spectra.	  

















































































Journal	  Name	   	  ARTICLE	  
This	  journal	  is	  ©	  The	  Royal	  Society	  of	  Chemistry	  20xx	   J.	  Name.,	  2013,	  00,	  1-­‐3	  |	  7 	  
Please	  do	  not	  adjust	  margins	  
Please	  do	  not	  adjust	  margins	  
STD	  NMR	  experiments	  were	  registered	  with	  3	  K	  scans	  by	  using	  
a	  train	  of	  Gaussian	  shaped	  pulses	  of	  49	  ms	  (field	  strength	  of	  ca.	  
80	  Hz),	  an	  inter-­‐pulse	  delay	  of	  1	  ms	  and	  15	  ms	  spin-­‐lock	  pulse	  
(field	  strength	  of	  3.7	  kHz)	  prior	  acquisition.	  The	  on-­‐resonance	  
frequency	  was	  set	  to	  0	  ppm	  while	  the	  off-­‐resonance	  frequency	  
was	  40	  ppm.	  Appropriate	  blank	  experiment	  was	  performed	  to	  
assure	   the	   lack	   of	   direct	   saturation	   of	   the	   ligand	   protons.	  
Saturation	  times	  of	  0.5,	  1	  and	  2	  s	  were	  used	  to	  obtain	  the	  STD	  
build-­‐up	   curves	   and,	   in	   each	   experiment,	   the	   recovery	   delay	  
(d1)	   was	   inversely	   varied	   relative	   to	   the	   saturation	   time,	   in	  
order	  to	  maintain	  constant	  the	  total	  time	  of	  the	  experiment.	  
The	   experimental	   STD	   growth	   curve	   (I0	   –	   Isat	   /	   I0)	   of	   H6ax	  
proton	   of	   cyclohexane	   ring	   could	   not	   be	   fitted	   to	   an	  
exponential	   function	   (equation:	   STD	   (tsat)	   =	   STDmax	   (1-­‐	   e	   –
ksat·∙tsat	  )),	  due	  to	  its	  fast	  relaxation.	  Therefore,	  instead	  of	  using	  
the	   analysis	   of	   initial	   slopes	   of	   the	   STD	   intensities,55	   the	  
binding	   epitope	   was	   characterized	   by	   using	   the	   shortest	  
saturation	   time	   (0.5	   s)	   to	   avoid	   artefacts	   due	   to	   differential	  
relaxation	   properties.	   The	   ligand	   epitope	   map	   was	   then	  
obtained	   by	   normalization	   of	   the	   whole	   set	   of	   the	   STD	  
intensities	  at	  0.5	  s	  against	  the	  highest	  STD	  value	  (proton	  H6ax	  




The	   Cartesian	   co-­‐ordinates	   of	   the	   crystal	   structure	   of	   the	  
complex	  DC-­‐SIGN	  CRD/pseudotrisaccharide	  2	   (pdb	  code	  2xr6)	  
were	  used	   for	   the	   full	   relaxation	  matrix	   calculations.	   In	  order	  
to	   explain	   the	   NMR	   data	   in	   solution,	   starting	   from	   the	   X-­‐ray	  
complex,	   further	   models	   of	   the	   interaction	   were	   built	   (see	  
above),	   and	   their	   Cartesian	   coordinates	   used	   for	   the	   full	  
relaxation	  matrix	  calculations.	  
As	   no	   chemical	   shift	   assignment	   of	   the	   protein	   protons	   was	  
available,	  they	  were	  predicted	  by	  using	  the	  program	  ShiftX	  1.1	  
(http://shiftx.wishartlab.com).	   Although	   the	   experimental	  
irradiation	   frequency	   for	   selective	   saturation	  was	   established	  
at	  0	  ppm,	  all	  the	  protein	  protons	  with	  chemical	  shifts	  predicted	  
to	  be	  within	  the	  [0.7,	  −0.7]	  ppm	  range	  were	  included,	  as	  ShiftX	  
56	  does	  not	   consider	   the	  effects	  of	   line	  broadening	  under	   the	  
experimental	   conditions.	   All	   exchangeable	   hydrogen	   atoms	  
were	   excluded	   in	   the	   calculations,	   as	   the	   STD	   NMR	  
experiments	   were	   performed	   in	   D2O.	   Identical	   PDB	  
coordinates	  for	  the	  bound	  and	  free	  protein	  were	  assumed	  and	  
to	  reduce	  the	  dimensions	  of	  the	  matrices,	  a	  cut	  off	  of	  8	  Å	  from	  
the	   ligand	   was	   used.	   Assuming	   a	   spherical	   shape	   for	   the	  
protein	  tetramer,	  the	  correlation	  time	  of	  bound	  ligand	  was	  set	  
to	  115	  ns	  whereas	  0.5	  ns	  was	  used	  for	  the	  free	  ligand,	  and	  10	  
ps	  for	  the	  internal	  correlation	  time	  of	  methyl	  groups.44	  For	  this	  
protein-­‐ligand	   system,	   the	   classical	   assumption	   of	   an	  
association	   step	   limited	   by	   diffusion	   (on-­‐rate	   108	  M-­‐1s-­‐1)	   was	  
considered.	   The	   experimentally	   determined	   KD	   value	   pseudo-­‐
trimannoside	  was	  used	   (5	  μM)	  and	   the	   resulting	  off-­‐rate	  was	  
500	  Hz.	  
The	   theoretical	   STD	   intensities	   for	   each	   binding	   mode	   were	  
calculated	   as	   percentage	   fractional	   intensity	   changes	   (Scalc,k	   =	  
(([(I0k	   –	   I(t)k)·∙100]/	   I0k),	   were	   k	   is	   a	   particular	   proton	   in	   the	  
complex,	   and	   I0k	   its	   thermal	   equilibrium	   value	   from	   the	  
intensity	  matrix	  I(t),	  and	  the	  calculation	  was	  carried	  out	  for	  the	  
whole	  set	  of	  saturation	  times	  	  experimentally	  measured.	  From	  
the	   resulting	   STD	  build-­‐up	   curves,	   a	  mathematical	   fitting	   to	  a	  
mono-­‐exponential	  equation	  (STD(tsat)	  =	  STDmax	  (1-­‐	  exp(-­‐ksat	  tsat	  
))	  was	  done,	  and	  the	  initial	  slope	  STD0,calc	  was	  obtained.	  
For	   the	   study	   of	   the	   bimodal	   system	   using	   the	   initial	   slope	  
approach:	  
	  
The	   STD0i	   contribution	   from	  each	   “i-­‐th”	  binding	  mode	  will	   be	  
proportional	   to	   the	   concentration	   of	   the	   complex	   in	   the	  
sample	   ([PLi];	   in	   this	   case,	   [PL1]	   or	   [PL2]),	   which	   will	   be	  
determined	   by	   its	   corresponding	   affinity	   (KD1	   or	   KD2).	  
Nevertheless,	  for	  this	  protein-­‐ligand	  system,	  the	  available	  data	  
was	  the	  dissociation	  constant	  from	  ITC	  measurements	  (KD	  =	  5	  
µM).25	  In	  this	  measurement,	  the	  global	  affinity	  of	  the	  DC-­‐SIGN	  
lectin	  for	  2	  was	  obtained,	  so	  no	   information	  on	  the	   individual	  
affinities	   of	   the	   potential	   different	   binding	   modes	   was	  
available.	  We	   then	   considered	   the	   final	   dissociation	   constant	  
from	   ITC	   as	   a	   weighted	   average	   of	   the	   different	   affinities	   of	  
each	  binding	  mode,	  and,	  as	  an	  approximation,	  calculated	  each	  
theoretical	  STD	  contribution	  using	  that	  value.	  By	  doing	  so,	  the	  
weighting	  of	  each	  complex	  must	  be	  done	  then	  by	  introducing	  a	  
population	  factor	  for	  every	  contributing	  complex	  (f1	  and	  f2,	  for	  
PL1	  and	  PL2,	  respectively,	  and	  f1	  +	  f2	  =	  1):	  
	  
	  
For	  this	  multimodal	  binding	  analysis	  of	  the	  STD	  data	  only	  those	  
protons	   that	   could	   be	   accurately	   integrated	   were	   used,	  
avoiding	   uncertain	   contributions	   in	   the	   case	   of	   overlapped	  
signals.	   The	   theoretical	   bimodal	   binding	   equilibrium	   was	  
considered	   in	  all	  cases	  as	  pair-­‐wise	  combinations	  of	   the	  X-­‐ray	  
structure	  with	  any	  one	  of	  the	  other	  three	  molecular	  models	  of	  
the	  complexes.	  (Fig.	  5),	  and	  the	  goodness	  of	  the	  prediction	  was	  
measured	  by	  the	  NOE	  R-­‐factor.	  
The	   theoretical	   STD	   values	   were	   compared	   to	   experimental	  
ones	  using	  the	  NOE	  R-­‐factor	  defined	  as:	  
	  
Wk (STD0,k





where	   STDexp0,k	   and	   STD
calc
0,k	   are	   the	   experimental	   and	  
calculated	   STD	   intensities,	   respectively,	   of	   proton	   k.	   A	   lower	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NOE	   R-­‐factor	   indicates	   better	   fit	   between	   experimental	   and	  
theoretical	   data	   and,	   thus,	   better	   appropriateness	   of	   the	  
chosen	  structural	  model	  of	  the	  complex.	  
	  
Molecular	  modelling:	  
Protein	   setup:	   By	   starting	   from	   the	   crystal	   structure	  
(resolution=1.55	  Å)	  of	  human	  DC-­‐SIGN	  in	  a	  complex	  with	  Man4	  
(PDB	   code	   1sl4),29	   a	   molecular	   model	   of	   the	   protein	   was	  
constructed.	   By	   using	   the	   Protein	   Preparation	   Wizard	   within	  
the	   Maestro	   graphical	   interface,57	   the	   crystal	   structure	   was	  
modified	  by	  deleting	  all	   crystal	  waters,	   assigning	  bond	  orders	  
and	   adding	   hydrogen	   atoms.	   Protonation	   states	   of	   basic	   and	  
acidic	  residues	  were	  assigned	  by	  optimization	  of	  the	  hydrogen-­‐
bonding	  network.	  A	  minimization	  was	  carried	  out	  on	  the	  final	  
protein	  structure	  by	  using	  the	  OPLS2005	  force	  field.58	  
Ligand	  conformational	  search:	  Models	  A,	  B,	  C,	  and	  D	  (based	  on	  
1→6	   torsional	   search,	  were	  prepared	  by	   varying	   the	  dihedral	  
angles	   Ψ	   and	   ω	   according	   to	   the	   most	   stable	   values	  
(conformers	  gg	  gt	  and	  tg)	  followed	  by	  a	  minimization	  by	  using	  
the	  OPLS2005	  force	  field.	  
Docking:	   The	   theoretical	   structures,	   named	   according	   to	   an	  
abbreviated	   nomenclature,	   "rotated”,	   "inverted",	   and	  
"inverted-­‐rotated",	   were	   obtained	   by	   rigid	   rotations	   and	  
translations	   of	   the	   ligand	   2	   within	   the	   DC-­‐SIGN	   binding	   site,	  
starting	   from	   the	   crystallographic	   position,	   based	   on	   a	   Ca2+	  
coordination	  search.	  All	  complexes	  were	  further	  minimized	  by	  
using	  the	  OPLS2005	  force	   field,57	  an	   implicit	  water	  model59,	   60	  
with	   constant	   dielectric,	   and	   with	   the	   van	   der	   Waals,	  
electrostatic	   and	   hydrogen	   bond	   cutoffs	   set	   to	   8,	   20,	   and	   4,	  
respectively.	   Some	   rotamers	   were	   slightly	   moved	   to	   avoid	  
steric	  problems	  and	  the	  final	  models	  correspond	  to	  the	  lowest	  
energy	   structures	   arising	   from	   conformational	   searches	   by	  
using	   a	   mixed	   torsional/low-­‐mode	   sampling	   method.61	   The	  
"rotated”	  model	   (E=	   -­‐1920.6	   kJ/mol)	  was	   obtained	   by	   a	   180º	  
rotation	  around	  an	  axis	  perpendicular	  to	  the	  C3-­‐C4	  bond	  of	  the	  
non-­‐reducing	  mannose,	   resulting	  an	   interaction	  “O4-­‐O3	  type”	  
with	  the	  Ca2+	  atom,	  rather	  than	  “O3-­‐O4”	  (in	  this	  nomenclature,	  
the	  Val351	  residue	   is	  always	  set	  on	  the	  right	  of	   the	  observer,	  
as	   a	   reference).	   In	   the	   "inverted"	  model	   (E=	   -­‐1871.2	   kJ/mol)	  
the	  reducing	  mannose	  (M')	   is	   interacting	  in	  the	  same	  position	  
of	  the	  non-­‐reducing	  sugar	  ring	  (M),	  as	   in	  the	  crystallized	  pose	  
(O3-­‐O4)	  and,	  in	  the	  "inverted-­‐rotated"	  (E=	  -­‐1894.8	  kJ/mol)	  the	  
coordination	   of	   the	   reducing	   mannose	   to	   Ca2+	   is	   rotated	   by	  
180º	  (O4-­‐O3	  type).	  
Conclusions	  
The	   analysis	   of	   the	   combined	   NMR	   data	   (STD-­‐NMR	   and	  
transfer	   NOESY)	   indicates	   that	   at	   high	   ligand	   to	   protein	   ratio	  
(52:1)	  the	  pseudo-­‐mannotrioside	  ligand	  2	  binds	  to	  DC-­‐SIGN	  in	  
a	  binary	  but	  multimodal	  fashion	  involving	  both	  mannose	  ends,	  
yielding	   two	   complexes	   with	   similar	   but	   asynchronous	  
interactions	  with	  the	  same	  Ca2+	  atom.	  The	  main	  binding	  mode	  
is	   similar	   to	   that	   from	   the	   X-­‐ray	   structure	   but	   with	  
participation	   of	   additional	   conformers	   originated	   from	   the	  
flexible	  1-­‐6	  linkage.	  
The	  involvement	  of	  both	  mannose	  residues	  of	  2	  in	  the	  binding	  
to	   DC-­‐SIGN	   is	   compatible	   with	   the	   outcomes	   from	   other	  
biophysical	  techniques	  (AUC,	  SLS	  and	  DLS).25	  At	  lower	  ligand	  to	  
protein	  ratio	  (5:1),	  the	  two	  mannose	  units	  of	  2	  cause	  clustering	  
of	   DC-­‐SIGN	   ECD	   by	   concurrent	   interactions	   of	   both	   residues	  
with	   two	   protein	   tetramers	   explaining	   the	   stronger	   binding	  
observed	   for	  2	   compared	  with	   the	   pseudo-­‐disaccharide	  1,	   as	  
we	  previously	  reported.62	  In	  addition,	  this	  model	  also	  explains	  
the	   reduction	   of	   the	   affinity	   difference	   between	   the	   two	  
ligands	   when	   they	   were	   tethered	   into	   multivalent	   systems	  
attached	   from	  their	   reducing	  ends,	  because	   this	  prevents	   the	  
second	  mannose	  unit	  of	  2	  from	  being	  involved	  in	  binding.25	  
In	   this	   work,	   as	   the	   NMR	   experiments	   have	   been	   registered	  
with	   a	   very	   large	   excess	   of	   ligand	   (52:1	   molar	   ratio)	   we	   can	  
ensure	   that	   no	   species	   other	   than	   1:1	   are	   observed	   by	   STD-­‐
NMR	  nor	  transfer	  NOESY.25	  Our	  results	  can	  be	  explained	  by	  the	  
existence	   of	   multiple	   binding	   modes	   of	   carbohydrate-­‐based	  
ligands	   upon	   interaction	   with	   DC-­‐SIGN	   as	   it	   has	   been	  
previously	   reported.18-­‐29	   STD	   NMR	   has	   proven	   to	   be	   very	  
sensitive	   to	   the	   existence	   of	   minor	   binding	   modes	   with	  
alternative	  orientations	  of	   the	   ligand	  within	  the	  same	  binding	  
site,	   18,	   21,	   23,	   30-­‐39	   and	   it	   avoids	   the	   possible	   loss	   of	   crucial	  
structural	   information	   resulting	   from	   the	   individual	   detection	  
of	  the	  major	  complex.	  We	  propose	  that	  this	  alternative	  mode	  
should	   be	   present	   in	   the	   ternary	   complex	   between	   DC-­‐SIGN	  
tetramers	  and	   the	  glycomimetic	  2	   recently	   reported	  by	   some	  
of	  us.25	  Therefore	  we	  suggest	  that	  the	  STD	  NMR	  approach	  for	  
the	  detection	  of	   bimodal	   binding	   involving	  other	  orientations	  
of	   the	   ligand	   can	   predict	   dimerization	   of	   protein	   by	   ligand	  
bridging	  interactions.	  
Herein,	  we	  provide	  not	  only	  a	  complete	  description	  of	  the	  DC-­‐
SIGN	   recognition	   process	   of	   glycomimetic	  2,	   but	  we	   propose	  
that	   STD	   NMR	   observation	   of	   bimodal	   binding	   involving	  
inverted	  orientations	  of	  the	   ligand	  can	  be	  used	  as	  a	  predictor	  
of	  protein	  dimer	   formation	  by	   ligand	  bridging	   interactions.	   In	  
this	   way,	   STD	   NMR	   studies	   can	   avoid	   misinterpretation	   of	  
affinity	  data	  under	  low	  ligand/protein	  ratio	  conditions	  in	  these	  
particular	   systems.	   In	   addition,	   this	   work	   highlights	   how	   a	  
multidisciplinary	   approach	   combining	   different	   experimental	  
methods	  with	  theoretical	  ones,	  is	  a	  highly	  appropriate	  strategy	  
for	   deeper	   structural	   characterization	   of	   weak	   protein-­‐
carbohydrates	  interactions.63	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